MAPT and Alzheimer disease: Therapeutic strategies targeting microglia-CD8+ T-cell interactions, such as microglial or T-cell depletion or the inhibition of IFN-γ signaling, may mitigate tau-mediated neurodegeneration and attenuate AD-associated neuroinflammation and neurodegenerative changes [22, 27].